Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Horizons in Cancer Research -

Horizons in Cancer Research

Volume 80

Hiroto S. Watanabe (Herausgeber)

Buch | Hardcover
265 Seiten
2021
Nova Science Publishers Inc (Verlag)
978-1-5361-9563-7 (ISBN)
CHF 379,95 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This edited volume presents six chapters detailing recent progress in the field of cancer research. Chapter One discusses the current information available regarding chemotherapy-induced peripheral neuropathy, including definition, prevalence, pathophysiology at nerve fibres, risk factors, physiology of specific antineoplastic agents on the peripheral nervous system, signs and symptoms, diagnostic criteria, and treatment methods. Chapter Two aims to substantiate the value of tumour-associated circulating and tissue miRNAs for assessing both the aggressiveness of the malignant process course and the sensitivity to neoadjuvant polychemotherapy (NPCT) in breast cancer patients of various molecular subtypes. Chapter Three summarizes the current role of nuclear factor kappa B (NF-κB) in cell aging, its dual functions in the balance of proliferation and apoptosis pathways and the current knowledge of not only the physiological but also the pathophysiological missions of NF-κB and its potential role as a target of therapeutic intervention against breast cancer. Chapter Four deals with 5-aminolevulinic acid radio-dynamic therapy for treatment of high-grade gliomas. Chapter Five presents a literature review to identify the possible role of sex hormone receptors in gender variation and sexual dimorphism in the genesis and progression of urothelial bladder cancer (UBC). Lastly, Chapter Six discusses the risk factors, diagnostic modalities, and outcomes of cholangiocarcinoma (CCA), the second most common primary hepatobiliary malignancy.

Preface; Chemotherapy-Induced Peripheral Neuropathy: From Diagnosis to Treatment; The Expression Profile of Tissue and Circulating miRNAs for Optimization of Neoadjuvant Therapy of Breast Cancer Patients; Current Mechanisms and Strategies for the Therapeutic Manipulation of NF-κB in Cell Aging and Breast Cancer; 5-Aminolevulinic Acid Radiodynamic Therapy for Treatment of High-Grade Gliomas; The Emerging Role of Sex Steroid Receptors in Urothelial Bladder Cancer; Cholangiocarcinoma: Diagnosis, Risk Factors and Outcome; Index.

Erscheinungsdatum
Sprache englisch
Gewicht 499 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 1-5361-9563-4 / 1536195634
ISBN-13 978-1-5361-9563-7 / 9781536195637
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 49,95